A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
D000328:Adult; D000912:Antibodies, Neoplasm / Q000096:biosynthesis; D000951:Antigens, Neoplasm / Q000032:analysis*; D001932:Brain Neoplasms / Q000276:immunology / Q000628:therapy*; D002460:Cell Line; D003131:Combined Modality Therapy; D005260:Female; D005910:Glioma / Q000276:immunology / Q000628:therapy*; D006680:HLA Antigens / Q000032:analysis*; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D006680:HLA Antigens